US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.47

+0.06200.18%

Volume:17.43K

Turnover:602.34K

Market Cap:95.83M

PE:- -

High:34.93

Open:34.93

Low:34.46

Close:34.41

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.82

T/O Rate:0.63%

Dividend:0.26

Dividend Rate:0.75%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication

Stocks to Watch: Amgen, Nike, Bloom Energy

Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks

Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy

Gilead Sciences (GILD) Receives a Buy from Bernstein

Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference

HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval

Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate

Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine

Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/IBBQ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.472,"timestamp":1789156800000,"preClose":34.41,"halted":0,"volume":17428,"delay":0,"changeRate":0.001801801801801939,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Pre-Mkt","change":0.062,"latestTime":"09-14 08:20:56 EDT","open":34.93,"high":34.93,"low":34.46,"amount":602342.09186,"amplitude":0.013659,"askPrice":55.15,"askSize":200,"bidPrice":33.97,"bidSize":14,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.472,"sharesOutstanding":2520001,"nav":34.42313,"aum":95742920.24,"dividendRate":0.007487,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.46,"preClose":34.472,"latestTime":"19:30 EDT","volume":73,"amount":2503.222,"timestamp":1789169407321,"change":-0.012,"changeRate":-0.000348,"amplitude":0},"volumeRatio":0.8243229216538044,"impliedVol":0.1122,"impliedVolPercentile":0.476},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8243229216538044,"shares":2780001,"dividePrice":0.2581,"high":34.93,"amplitude":0.013659,"preClose":34.41,"low":34.46,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.472,"committee":-0.869159,"eps":0,"divideRate":0.007487,"volume":17428,"delay":0,"ttmEps":0,"open":34.93,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.26,"twentyDayClose":33.9144,"sixtyDayClose":29.6382},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1194747479","title":"Cholesterol Drug Trial Setback Casts Doubt on Multi-Billion Rivalry","url":"https://stock-news.laohu8.com/highlight/detail?id=1194747479","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194747479?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:40","pubTimestamp":1788860434,"startTime":"0","endTime":"0","summary":"Novartis's closely watched cardiovascular trial has failed, raising significant questions about one of the pharmaceutical industry's most prominent drug development races and casting uncertainty over...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","MDTX","PSYK","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326246","title":"Amgen Falls After Novartis Trial Setback, BMO Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326246?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859626,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen falls after Novartis trial setback, BMO downgrade** Shares of AmgenAMGN.Oslip 4.8% to $416 premarket** Novartis'NOVN.Scholesterol drug failed in a closely watched study,raising concernsfor ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500KO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IBBQ","IE0009355771.USD","BK4599","IE00B2B36J28.USD","PJP","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","BK4533","BBH","LU1023059063.AUD","LU2112291526.USD","BK4534","LU2468319806.SGD","BK4139","LU2242646821.SGD","LU1983299246.USD","AMGN","LU2089984988.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1571399168.USD","BK4581","PBE","TBXU","BK4566","BIB","BK4585","LU2242652126.USD","LU0868494617.USD","LU0058720904.USD","IE0002141913.USD","SG9999001440.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132147233","title":"Fosun Pharma's Subsidiary Obtains Regulatory Nod for FXS5626 Tablet Trial in Vitiligo Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1132147233","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132147233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:20","pubTimestamp":1788859248,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SH: 600196) has announced that its controlling subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","IBBJ","BK0060","IBBQ","PSYK","BK0239","BK1191","BK0188","BK0196","02196","BK1515","600196","MDTX","BK0028","BK0187","BK0096","BK0175","BK0012","BMED","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342326","title":"Stocks to Watch: Amgen, Nike, Bloom Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342326?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858420,"startTime":"0","endTime":"0","summary":"Amgen : Shares of the biotechnology company, a major contributor to the Dow, shed more than 5% premarket after the Swiss drugmaker Novartis  said an experimental medicine failed to reduce cardiovascular risk in a late-stage clinical trial. Amgen and Eli Lilly  are working on rival treatments. Novartis shares tumbled 10% in Europe, while Eli Lilly shares ticked down.Bloom Energy : The fuel-cell maker is among the companies that will join the S&P 500 later this month, S&P Dow Jones Indices announced late Friday, sending its shares 4% higher premarket. Meanwhile, Nike  will be deleted from the S&P 100. Its shares edged lower premarket.Coinbase Global , Robinhood Markets , Strategy : Shares of companies tied to cryptocurrencies retreated in premarket trading as bitcoin's price slipped more than 1% to trade below $78,500.GameStop  is set to report earnings after markets close.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYY","BK4146","IE0009354923.USD","LU0052756011.USD","MSST","BK4566","IE00BJJMRZ35.SGD","BK4577","BPAY","BBH","LU2089984988.USD","LU2357125470.USD","LU0823414478.USD","ROBN","COIA","VCLN","BK4588","BK4007","MSTY.UK","LU0128525689.USD","AMGN","SG9999001440.SGD","HOOZ","LU0476273544.USD","LU2264538146.SGD","CONI","LU2242646821.SGD","07399","LU1861220207.SGD","LU2242652126.USD","CONY","PJP","LU0823414551.USD","BK4561","LU2249611893.SGD","HOII","3SMI.UK","BK4112","LU2098885051.SGD","LU0823411888.USD","IMST","LU1983299246.USD","CONL","ZAP","07311","COIG","HOOI","MSDD","MSTZ","BIB","BK4595","LU1267930573.SGD","HOOW","BK4599","MSTY","LU0211331839.USD","BK4534","BK4539","LU0708994859.HKD","IE00B4R5TH58.HKD","BK4541","APED","COII","IE00BFTCPJ56.SGD","DAPP","COIO","TBXU","HOOC","LU0889566641.SGD","07799","GME","LU0310800379.SGD","CTEC","LU1861558580.USD","BKCH","09399","IBB","SMI3.UK","LU0320765992.SGD","CRPT","FRNW","LU0444973449.USD","LU0889565916.HKD","WNTR","BK4023","BEG","BK4127","LU0208291251.USD","LU1064131342.USD","LU1988902786.USD","LU0070302665.USD","MSOO","HOYY","LU0058720904.USD","ICLN","07711","LU2543165471.USD","LU0444971666.USD","FINX","LU1815336760.USD","BK4516","VTWG","BK4554","COIX","MST","COIW","GMEY","04332","STYL","ICOI","LU0029864427.USD","BLCK","BK4578","IAI","LU0122379950.USD","09311","LU1057294990.SGD","LU0310800965.SGD","MSTW","LU0957808578.USD","MSTP","IE00BYQQ9H92.USD","IBLC","WATS","CNRG","IE00B2B36J28.USD","IE0002141913.USD","BK4600","MSTR","BK4581","BK4551","EGGY","BK4533","LU2294711713.HKD","HOOD","IBBQ","MEDX","BK4076","HODU","PPH","LU1303367103.USD","LU2360107671.USD","BK4547","GMEU","LU1023059063.AUD","MSTU","IGME","BEZ","IE0009355771.USD","IBAT","LU0289739699.SGD","LU0792757196.USD","SIMS","SMOG","BEC","LMI3.UK","GMEC","HOOG","3LMI.UK","MSII","PBE","BK4182","OWNB","LU0786609619.USD","BE","LU2506951792.HKD","COIN","NVS","MSTK","LU2468319806.SGD","FIAT","LU0320765489.SGD","BK4558","BK4139","LU0109394709.USD","09711","LU2112291526.USD","LU1861559042.SGD","BEX","IE00BFXG0V08.USD","09799","BITQ","BK4535","HOOY","LU1642822529.SGD","NKE","BK4585","BK4596","LU1061106388.HKD","UPGR","LU1861217088.USD","MSTC","CONX","LU1571399168.USD","MSTX","SMST","LU0128525929.USD","LU0868494617.USD","HOOX","LU1267930813.SGD","MTYY","BK4532","LU1267930227.SGD","IE00BJT1NW94.SGD","FDIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125754221","title":"Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1125754221","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125754221?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:00","pubTimestamp":1788858037,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical heavyweight Novartis faced a turbulent trading session on Tuesday as its shares tumbled sharply following the disclosure that its experimental drug for muscular dystrophy,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BK4578","NVS","MEDX","MDTX","BK4588","LU0211331839.USD","LU0320765489.SGD","PSYK","BMED","IE00BFTCPJ56.SGD","IE0009355771.USD","PPH","BK4585","IBBJ","IE00BJT1NW94.SGD","BK4532","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0208291251.USD","IBBQ","LU0070302665.USD","BK4007","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179120005","title":"Medprin Regenerative Medical Technologies Advances Absorbable Hemostatic Gel to Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1179120005","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179120005?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:28","pubTimestamp":1788856093,"startTime":"0","endTime":"0","summary":"Medprin Regenerative Medical Technologies Co., Ltd. (301033.SZ) has officially announced that its research project involving the \"absorbable hemostatic fluid gelatin\" has recently entered the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301033","BK0251","PSYK","IBBQ","IBBJ","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665230393","title":"Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665230393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665230393?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:27","pubTimestamp":1788856044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","BK4585","LU0868494617.USD","LU2112291526.USD","SG9999001440.SGD","BK4139","PJP","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1571399168.USD","TBXU","LU0289739699.SGD","LU0320765992.SGD","BK4581","IBBQ","LU0889565916.HKD","LU1057294990.SGD","BK4599","IBB","LU0122379950.USD","IE0002141913.USD","IE0009355771.USD","LU1061106388.HKD","LU2089984988.USD","BK4588","PBE","BK4566","BK4534","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","BIB","LU2468319806.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B2B36J28.USD","AMGN","BBH","LU2242646821.SGD","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0868494617.USD","BK4585","LU0889565916.HKD","IE0002141913.USD","LU1983299246.USD","BIB","BK4532","IE00BJJMRZ35.SGD","LU2468319806.SGD","NVS","BK4588","LU2242652126.USD","LU2089984988.USD","BK4581","IE00B2B36J28.USD","LU0058720904.USD","SG9999001440.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","PPH","BK4566","BK4599","LU1061106388.HKD","BK4534","BK4578","LU0109394709.USD","MEDX","IE00BFTCPJ56.SGD","LU0208291251.USD","PBE","LU0320765489.SGD","BK4533","PJP","LU2112291526.USD","LU0320765992.SGD","IBB","BBH","LU0070302665.USD","BK4139","BK4007","TBXU","LU0289739699.SGD","LU1571399168.USD","IE0009355771.USD","NAMS","LU0211331839.USD","IBBQ","LU0122379950.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665101723","title":"Milton Essex boosts Sanford Biotech capital to drive advanced mastitis cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2665101723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665101723?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:47","pubTimestamp":1788806848,"startTime":"0","endTime":"0","summary":"MILTON ESSEX S.A. ( ($PL:MTN) ) just unveiled an announcement. Milton Essex S.A., acting as sole shareholder of Sanford Biotech, has approved a PLN...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/milton-essex-boosts-sanford-biotech-capital-to-drive-advanced-mastitis-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","CNCR","LFSC","IBBQ","IBB","TBXU","GNOM","BK4581","MTNmain","SYNB","BK4588","FBT","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","LU0823416689.USD","BK4581","LU2468319806.SGD","SG9999015952.SGD","LU0289739699.SGD","LU1934455194.USD","LU1037948541.HKD","LU0965508806.USD","LU1934455863.HKD","LU2089984988.USD","SG9999015945.SGD","LU1674673428.USD","LU0114720955.EUR","BIB","LU1778281490.HKD","BK4588","IE00B7SZLL34.SGD","BK4550","LU2112291526.USD","IE00BZ1G4Q59.USD","BK4566","IE00B19Z3B42.SGD","LU1934455277.USD","LU1585245621.USD","IE00B3T34201.USD","IBB","IE00BSNM7G36.USD","LU2324357040.USD","BK4578","SG9999015978.USD","IBBQ","BBH","XLV","TBXU","IE00BKVL7J92.USD","LU0882574055.USD","BK4139","LU1839511570.USD","BMED","LU0122379950.USD","IE0002270589.USD","XBI","GILD","TMED","BK4585","LABU","LU1066051498.USD","MEDI","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106718626","title":"Jiangsu Aidea Pharmaceutical to Join Specialised Earnings Briefing for Innovative Drug Firms on STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1106718626","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106718626?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:51","pubTimestamp":1788781895,"startTime":"0","endTime":"0","summary":"Jiangsu Aidea Pharmaceutical Group Co., Ltd. (688488) has disclosed its intention to participate in a collective earnings presentation tailored for the innovative drug sector on the STAR Market,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK1574","IBBQ","BK1161","MEDX","159992","KSTR","06978","BK0262","688488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199113939","title":"CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1199113939","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199113939?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:36","pubTimestamp":1788780985,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase II clinical trial of its SYH2085 tablet, designed for the treatment of uncomplicated influenza in adults, has formally commenced at the first clinical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","IE00BZ08YT58.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1226288170.HKD","01093","LU0314109678.HKD","LU0880133367.SGD","LU0067412154.USD","LU1993786604.SGD","LU0140636845.USD","LU1226288253.USD","BMED","BK1515","LU1152091168.USD","LU1807302812.USD","LU1008478684.HKD","LU1813983027.USD","LU0501845795.SGD","LU0326950275.SGD","PSYK","LU1960683339.HKD","IBBJ","IE00B5MMRT66.SGD","KURE","LU0072913022.USD","IE00B543WZ88.USD","MDTX","IBBQ","LU0315179316.USD","LU1152091754.HKD","LU1951186391.HKD","SG9999004220.SGD","BK1191","BK1521","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0008368742.USD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143231072","title":"Remegen Announces Participation in Nasdaq-Style STAR Market Biopharma Sector Earnings Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1143231072","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143231072?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:20","pubTimestamp":1788780027,"startTime":"0","endTime":"0","summary":"Remegen Co., Ltd. announced on September 7 that it will join the collective earnings communication session for the innovative drug industry on the STAR Market for the first half of 2026, scheduled...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","KSTR","LU1064130708.USD","LU2488822045.USD","06978","159992","IBBQ","LNGR","LU1064131003.USD","BK1574","BK1583","688331","MEDX","LU2148510915.USD","09995","LU2328871848.SGD","BK0239","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187160052","title":"HENGRUI PHARMA Advances Pipeline with SHR-1179 Injection Clinical Trial Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1187160052","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187160052?lang=en_us&edition=fundamental","pubTime":"2026-09-07 18:52","pubTimestamp":1788778333,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has announced that its subsidiary, Guangdong Hengrui Pharmaceutical Co., Ltd., has recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","BK0239","BK1191","600276","LU1580142542.USD","LU1820825898.SGD","LU1969619763.USD","LU2097828474.EUR","LU1146622755.USD","LU2289578879.USD","LU2488822045.USD","MDTX","LU1255011170.USD","LU0359201885.HKD","LU2097828805.USD","BK0183","LU2148510915.USD","LU1064130708.USD","LU1328615791.USD","IBBJ","LU0359201612.USD","BK0188","LU2543165471.USD","LU0359202008.SGD","LU1023057109.AUD","PSYK","BK0012","LU2580892862.HKD","LU2097828714.EUR","LU0405327148.USD","LU0405327494.USD","LU1655091616.SGD","LU1997245177.USD","BK0028","IBBQ","LU2328871848.SGD","LU2495084118.USD","LU2580892789.USD","BMED","LU1997244956.HKD","BK0060","LU1997245094.SGD","BK0196","01276","LU1064131003.USD","LU1781817850.SGD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110897642","title":"Hengrui Pharma Subsidiary Gains Clinical Trial Approval for Weight Management Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1110897642","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110897642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:22","pubTimestamp":1788772938,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SH: 600276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently received the Drug Clinical Trial Approval Notice issued...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","LU2543165471.USD","LU0359202008.SGD","LU1064131003.USD","LU2488822045.USD","LU0359201885.HKD","LU2097828805.USD","BMED","LU2097828714.EUR","LU2580892862.HKD","LU1781817850.SGD","LU1064130708.USD","BK0196","LU1997245094.SGD","BK0012","BK0183","01276","LU1820825898.SGD","LU1023057109.AUD","BK0239","LU1655091616.SGD","LU2289578879.USD","LU2328871848.SGD","LU1997245177.USD","LU2097828474.EUR","PSYK","BK0060","BK0188","BK1191","LU1146622755.USD","LU2097828557.USD","LU2580892789.USD","IBBQ","LU2495084118.USD","LU1997244956.HKD","LU1969619763.USD","LU0405327494.USD","LU2097828631.EUR","600276","LU2148510915.USD","LU1255011170.USD","LU1328615791.USD","LU1580142542.USD","LU0359201612.USD","MDTX","BK0028","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176376860","title":"Chongqing Zhifei Biological Receives Clinical Trial Approval for Recombinant Rotavirus Subunit Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1176376860","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176376860?lang=en_us&edition=fundamental","pubTime":"2026-09-07 17:20","pubTimestamp":1788772824,"startTime":"0","endTime":"0","summary":"Chongqing Zhifei Biological Products Co.,Ltd. (300122.SZ) has announced that its wholly-owned subsidiary, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd., has obtained a drug clinical trial approval...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK0046","IBBJ","BMED","MDTX","IBBQ","LU1064131003.USD","LU2580892862.HKD","LU1064130708.USD","LU2580892789.USD","LU1328615791.USD","159646","300122","BK0188","BK0239","PSYK","LU2148510915.USD","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162474456","title":"Hualan Vaccine's Novel Influenza mRNA Vaccine Clears Clinical Trial Hurdle, No Domestic Competitors Yet","url":"https://stock-news.laohu8.com/highlight/detail?id=1162474456","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162474456?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:51","pubTimestamp":1788771108,"startTime":"0","endTime":"0","summary":"Hualan Biological Vaccine Inc. (301207.SZ) announced it has received the \"Drug Clinical Trial Approval Notice\" from the National Medical Products Administration for its novel influenza virus mRNA...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","MRNY","MDTX","IBBQ","PSYK","MRNX","IBBJ","BK0239","301207","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","01177","IE00BZ08YT58.USD","BK1521","IBBQ","BK1191","IE0009355771.USD","BK4599","IE00B2B36J28.USD","PJP","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","BK1515","BBH","BK4533","LU1023059063.AUD","LU2112291526.USD","BK4534","BK1589","BK4139","LU2468319806.SGD","LU2242646821.SGD","LU1983299246.USD","AMGN","LU2089984988.USD","LU0320765992.SGD","IBB","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","HK0000165453.HKD","LU0109394709.USD","LU1571399168.USD","BK4581","PBE","TBXU","BK4566","BIB","BK4585","LU2242652126.USD","LU0868494617.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU0058720904.USD","IE0002141913.USD","SG9999001440.SGD","LU1061106388.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182662414","title":"Anglikang's Transformation Challenge: Legacy Businesses Stall While Innovative Drug Bet Faces Uncertain Future","url":"https://stock-news.laohu8.com/highlight/detail?id=1182662414","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182662414?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:21","pubTimestamp":1788769307,"startTime":"0","endTime":"0","summary":"Shares of Zhejiang Anglikang Pharmaceutical Co.,Ltd. (002940.SZ) briefly hit the daily limit up on September 4th, buoyed by news of medical insurance negotiations and the launch of commercial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK0239","06978","002940","MEDX","159992","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MHIP","IYH","TRUH","GDOC","PBE","BBH","THNR","LLY","LU0097036916.USD","AMGN","LLII","IE00BJJMRY28.SGD","LU1571399168.USD","CURE","FHLC","LU0823434583.USD","LU2750360641.GBP","MEDX","CANC","LU2089284900.SGD","TBXU","LU1691799644.USD","SLN","LLYZ","FTXH","JDOC","TMED","BIB","VHT","LU2361044865.SGD","ELIS","OZEM","RXL","IHE","IBBQ","LU1267930730.SGD","PJP","IXJ","XLV","ELIL","HRTS","ILDR","AGNG","NAMS","IBB","MEDI","WDNA","PPH","LLYX","SGXZ99366536.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}